Fundraising Fox

Alexander Vos

Investor

Venture Partner at BioGeneration Ventures

Netherlands

Writes $100K – $1M checks · typically $500K

About

Alexander Vos is Chairman of the Board at Scenic Biotech and Managing Director of Biotech Mountains. He has held executive and board positions in biopharmaceuticals, with experience in orphan and rare diseases, cell and gene therapy, strategy, investor relations, and mergers and acquisitions. He holds an MBA from Stanford University Graduate School of Business.

Experience

  1. Scenic BiotechChairman of the Boardcurrent2025 — presentAmsterdam, North Holland, Netherlands
  2. RoslinCTMember Board of Directorscurrent2024 — presentEdinburgh (Scotland) and Boston area (USA)
  3. InnoCore PharmaceuticalsChairman of the Boardcurrent2024 — presentGroningen, Netherlands
  4. Teknova Inc.Member Board Of Directorscurrent2021 — presentHollister, California, United States
  5. BGV (BioGeneration Ventures)Venture Partnercurrent2019 — presentNaarden
  6. Biotech Mountains BVManaging Directorcurrent2018 — presentMaastricht
  7. CiMaas BVMember of the Supervisory Board2018 — 2024Maastricht
  8. VectorY TherapeuticsChief Executive Officer2021 — 2023Amsterdam
  9. VectorY TherapeuticsSenior Advisor - General management, corporate strategy2020 — 2021Amsterdam
  10. SymeresChairman Of The Board2018 — 2021Nijmegen, Groningen
  11. VarmXChief Executive Officer2018 — 2021Leiden, The Netherlands
  12. Alliance for Regenerative MedicineMember Board of Directors2015 — 2018Washington D.C.
  13. PharmaCell B.V.Chief Executive Officer (CEO)2009 — 2017The Netherlands
  14. Medisse BVMember of the Supervisory Board2010 — 2015Leusden, The Netherlands
  15. Alliance for Advanced Therapies, EuropeExecutive Committee2012 — 2015Brussels
  16. Biomedical MaterialsMember of the Supervisory Board2011 — 2014The Netherlands
  17. PAION AGChief Executive Officer (Deputy) and Chief Operating Officer2004 — 2009Germany
  18. MediService AGChief Executive Officer2000 — 2004Switzerland
  19. Genzyme Europe B.V.Director Business Development1994 — 1999
  20. McKinsey & CompanyEngagement Manager1989 — 1994

Education

  1. Stanford University Graduate School of BusinessDirector’s Consortium - Public Company Directors Program2023
  2. GLH – Centrum für Strategie und Höhere FührungPrivatissimum für Aufsichtsräte und Beiräte2018
  3. Stanford University Graduate School of BusinessMaster of Business Administration (M.B.A.), Business Administration1987 — 1989
  4. Mayo Clinic Alix School of MedicinePharmacology1986
  5. University of AmsterdamM.Sc., Pharmacy / Pharmacology1980 — 1986
  6. Titus Brandsma Lyceum (Oss)Gymnasium (beta), Grammar School - Math and Science program1974 — 1980

Skills & more

Cell Therapy4Biotechnology23Lifesciences7Clinical Trials7Licensing3Corporate FinanceInvestor RelationsMarketing1Sales Management1Business Development10Business Acquisition1Board of Director experience1
+9 moreOperations ManagementLife SciencesBoard of DirectorsBiopharmaceuticalsOncologyStart-upsStrategic PlanningStrategyPharmaceutical Industry

Languages Dutch · English · French · German

From Alexander's professional profile.

Colleagues at BioGeneration Ventures

Andree Blaukat
Senior Advisor at BioGeneration Ventures
Arnon Kater
Senior Advisor at BioGeneration Ventures
Arnoud Dijkstra
Venture Partner at BioGeneration Ventures
Claire van Viersen
Executive Assistant at BioGeneration Ventures
Cyril Lesser
Vice President Finance | Funds at BioGeneration Ventures
Daniela Couto
General Partner at BioGeneration Ventures
Diede Brunen
Principal at BioGeneration Ventures
Edward van Wezel
Managing Partner at BioGeneration Ventures

Network5

Arnoud Dijkstra
Venture Partner at BioGeneration Ventures
Daniela Couto
General Partner at BioGeneration Ventures
Diede Brunen
Principal at BioGeneration Ventures
Edward van Wezel
Managing Partner at BioGeneration Ventures
Joost Holthuis
Venture Partner at BioGeneration Ventures

Investors connected to Alexander in public investor directories — a warm-intro map.

Frequently asked questions

Where does Alexander Vos work?
Alexander Vos is Venture Partner at BioGeneration Ventures.
What check size does Alexander Vos write?
Alexander Vos typically writes checks of $100K – $1M.

Founder mafias

McKinsey & Company mafia325

Also came through, then founded or led a company.

Elad GilConsultantFounded Brain Co.Inaki BerenguerAssociateFounded InfiniteWatch +2Ryan XueManagement ConsultantFounded Andco +2Max AhrensFellow InternFounded Maihem +2Pedro SicilianoBusiness AnalystFounded Teachy +1Shantanu AgarwalSummer AssociateFounded Sustaera +1

+ 318 more

Stanford University Graduate School of Business mafia256

Also came through, then founded or led a company.

Steve JurvetsonMaster of Business Administration (MBA)Founded Mojo VisionMatt RouifStanford Ignite (Summer Institute for Entrepreneurship)Founded Photoroom +3IanMaster of Business Administration (M.B.A.)Founded Immunity Project +2Mikhail KokorichStanford Executive ProgramFounded Destinus +2Jesse BuckinghamMaster of Business Administration (M.B.A.)Founded Vooma +2Don MuirMaster of Business Administration - MBAFounded Arc +2

+ 249 more

University of Amsterdam mafia27

Also came through, then founded or led a company.

Helmuth van EsDoctor of Philosophy (PhD)Founded Antabio +1Sebastian BrunemeierMScFounded Cyclone Therapeutics +1Daniel HavenFounded Slauth.io +1Margot EngelsMasterFounded Holland CapitalMaarten EngelenArtificial IntelligenceFounded HiberBen WhiteResearch MasterFounded Vc4A

+ 20 more

BioGeneration Ventures mafia2

Also came through, then founded or led a company.

Rafiq HasanSenior AdvisorFounded Complement Therapeutics

Same school

Also attended Stanford University Graduate School of Business1,293

Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew

+ 1,287 more

Also attended Mayo Clinic Alix School of Medicine5

Andrew ElBardissiPartner at Deerfield Management CompanyCarlos PayaVenture Partner at Ysios CapitalRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesMichael MatlyManaging Partner at West CapitalSilke R. SperlingManaging Partner at Catalpa Ventures

Also attended University of Amsterdam174

TorjusInvestor at InvestinorDamien van der BijlInvestment Director at Capricorn Venture PartnersAndrea van ElsasInvestor at Third Rock VenturesFreya WordsworthAssociate at Nauta CapitalEmil SchaeferInvestor at Index VenturesDjoni de VosPrincipal at Keen Venture Partners

+ 168 more

Shared employers

Also worked at Scenic Biotech9

Alexandra (Sandra) GlucksmannAdvisory Partner at Adjuvant CapitalMichael WackerManaging Partner at BioMedPartnersEdward van WezelManaging Partner at BioGeneration VenturesThijs Cohen TervaertPartner at InkefSimone BottiSenior Partner at InkefAndrew McLeanManaging Partner at Tin Alley Ventures

+ 3 more

Also worked at McKinsey & Company1,457

Elad GilSolo general partner investing through Gil CapitalJim BreyerFounder & CEO of Breyer CapitalAnn Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture Partners

+ 1,451 more